111 (YI) Preferred Stock Liabilities (2017)
111 (YI) posted Preferred Stock Liabilities of $227.8 million for Q4 2017.
111 (YI) Preferred Stock Liabilities (2017) Analysis & Trends
111 has reported Preferred Stock Liabilities for 1 years, with the latest figure at $227.8 million in Q4 2017.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $227.8 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $227.8 million (changed N/A YoY) and the FY2017 annual result came in at $223.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $227.8 million in Q4 2017 per YI's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $227.8 million in Q4 2017 and troughed at $227.8 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 227.76 Mn |